Last years Complement-based Drug Development Summit was the first industry-dedicated meeting that focused on the research and development of therapeutics to inhibit the complement pathway, providing safe and effective cures for a range of disease indications.
Across 3 content-packed days, the field’s thought leaders from Alexion, Ra Pharma, Apellis, GSK, Bioverativ, Alnylam and many more shared their insight and lessons learned, collectively enabling the community to:
Join your peers in Boston this November 2018 to gain unique and novel insights into methods to accelerate your complement-based drug development. Register your interest today!
Testimonials from our Past Events in the Cell and Viral Immunotherapy Space:
“Overall an excellent programme with topical presentations and great opportunities to network with leaders in the field. The fact that it was a relatively small meeting with high level people made such interactions possible and made it hugely valuable.” Past CVI Summit Attendee, Virttu Biologics
“This was an amazing meeting with a terrific turnout and engagement by industry. The advances in technology being made and the issues being addressed were extremely eye-opening.” Past CVI Summit Attendee, Prescient Healthcare
“This meeting gathered all experts in the field to share ideas and data. It was quite an eye opener. I feel I came home with excitement and a brand new mind towards my work in the field.” Past CVI Summit Attendee, Pfizer